Streetbeat News

Stock Prices

GETY

Getty Images shares are trading lower after Macquarie lowered its price target on the stock from $4 to $3.5.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 6:01 pm

PCRX

Analysts have mixed ratings for Pacira BioSciences (NASDAQ:PCRX), with a recent decline in the average 12-month price target by 25.15%. The company has shown solid financial performance with notable revenue growth, net margin, ROE, and ROA, but analysts have lowered their price targets and ratings in response to market conditions.

Portfolio Pulse from Benzinga Insights

August 12, 2024 | 6:00 pm

SKIN

Over the past three months, four analysts have shared their insights on Beauty Health (NASDAQ:SKIN), with opinions ranging from indifferent to somewhat bearish. The average 12-month price target has declined from $2.50 to $1.44, reflecting a 42.4% decrease. Recent analyst actions include downgrades and lowered price targets, indicating a cautious outlook on the company's performance.

Portfolio Pulse from Benzinga Insights

August 12, 2024 | 6:00 pm

AON

Aon (NYSE:AON) has outperformed the market over the past 10 years with an average annual return of 14.33%, resulting in a $1000 investment growing to $3,838.79. The article highlights the impact of compounded returns on long-term investments.

Portfolio Pulse from Benzinga Insights

August 12, 2024 | 6:00 pm

LRCX

Lam Research (NASDAQ:LRCX) has significantly outperformed the market over the past 10 years, delivering an average annual return of 27.44%. A $1000 investment in LRCX 10 years ago would be worth $11,369.89 today. The article highlights the power of compounded returns.

Portfolio Pulse from Benzinga Insights

August 12, 2024 | 6:00 pm

TSHA

Analysts have mixed opinions on Taysha Gene Therapies (NASDAQ:TSHA), with recent ratings showing a shift in sentiment. The average 12-month price target has decreased by 5.43%, with a current average of $6.62. Financial performance indicators reveal challenges, including a -27.52% decline in revenue growth and a high debt-to-equity ratio of 1.13.

Portfolio Pulse from Benzinga Insights

August 12, 2024 | 6:00 pm

PACB

Pacific Biosciences of California shares are trading lower after Morgan Stanley lowered its price target on the stock from $4 to $2.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 5:59 pm

KHC

Kraft Heinz shares are trading lower after Goldman Sachs initiated coverage on the stock with a Sell rating and announced a price target of $34.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 5:50 pm

PLD

Prologis shares are trading lower after B of A Securities downgraded the stock from Buy to Neutral.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 5:48 pm

MSFT

UPWK

Upwork has integrated OpenAI's technology across its operations, product development, and team productivity. This includes new AI-powered features like Job Post Generator, Upwork Chat Pro, Proposal Tips, and Best Match insights. Upwork has also launched Uma, an AI companion, and implemented fraud detection using GPT-4o. Additionally, Upwork team members are using ChatGPT Enterprise for various tasks, and the platform has created resources to connect freelancers skilled in OpenAI technologies with clients.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 5:48 pm